Join
Live feed
·
PRReleasevia Quantisnow
Senti Biosciences Inc. logo

Senti Bio Participates in Virtual Investor "What This Means" Segment Discussing The Phase 2 Dose and Schedule Selection for SENTI-202 in its Clinical Trial for Acute Myeloid Leukemia

ByQuantisnow·Wall Street's wire, on your screen.
SNTI· Senti Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SNTI (Senti Biosciences Inc.) and more on Quantisnow.